title: Novel electrospun nanofibrous matrices prepared from poly(lactic acid)/poly(butylene adipate) blends for controlled release formulations of an anti-rheumatoid agent.
abstract: In the present work, a series of novel formulations consisting of poly(lactic acid)/poly(butylene adipate) (PLA/PBAd) electrospun blends was examined as controlled release matrices for Leflunomide's active metabolite, Teriflunomide (TFL). The mixtures were prepared using different ratios of PLA and PBAd in order to produce nanofibrous matrices with different characteristics. Miscibility studies of the blended polymeric fibers were performed through differential scanning calorimetry (DSC) and X-ray diffractometry (XRD). Hydrolytic degradation in the prepared fibers was evaluated at 37°C using a phosphate buffered saline solution. Different concentrations of (TFL) (5, 10, 15wt.%) were incorporated into nanofibers for examining the drug release behavior in simulated body fluids (SBF), at 37°C. The drug-loaded nanofibrous formulations were further characterized by Fourier Transform Infrared Spectroscopy (FTIR) spectroscopy, DSC and XRD. Gel permeation chromatography (GPC) analysis was used to evaluate the mechanism of TFL release. Artificial neural networks (ANN) and multi-linear-regression (MLR) models were used to evaluate the effect of % content of PBAd (X1) and TFL (X2) on an initial burst effect and a dissolution behavior. It was found that PLA/PBAd nanofibers have different diameters depending on the ratio of used polyesters and added drug. TFL was incorporated in an amorphous form inside the polymeric nanofibers. In vitro release studies reveal that a drug release behavior is correlated with the size of the nanofibers, drug loading and matrix degradation after a specific time. ANN dissolution modeling showed increased correlation efficacy compared to MLR.
authors.affiliation: Laboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Macedonia, Greece.
authors.forename: Panoraia I
authors.initials: PI
authors.lastname: Siafaka
authors.affiliation: Laboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Macedonia, Greece.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Barmbalexis
authors.affiliation: Laboratory of Polymer Chemistry and Technology, Department of Chemistry, Aristotle University of Thessaloniki, GR-54124, Macedonia, Greece. Electronic address: dbic@chem.auth.gr.
authors.forename: Dimitrios N
authors.initials: DN
authors.lastname: Bikiaris
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000737:chemistry*; D001672:Biocompatible Materials; D002072:Butylene Glycols / Q000737:chemistry*; D002460:Cell Line; D003437:Crotonates / Q000008:administration & dosage / Q000737:chemistry* / Q000633:toxicity; D003692:Delayed-Action Preparations; D065546:Drug Liberation; D055664:Electrochemical Techniques; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D006885:Hydroxybutyrates; D007555:Isoxazoles / Q000737:chemistry; D000077339:Leflunomide; D016014:Linear Models; D008855:Microscopy, Electron, Scanning; D008956:Models, Chemical; D057139:Nanofibers / Q000737:chemistry*; D016571:Neural Networks, Computer; D009570:Nitriles; D011091:Polyesters / Q000737:chemistry*; D011108:Polymers / Q000737:chemistry*; D014052:Toluidines / Q000008:administration & dosage / Q000737:chemistry* / Q000633:toxicity
chemical_list: D018501:Antirheumatic Agents; D001672:Biocompatible Materials; D002072:Butylene Glycols; D003437:Crotonates; D003692:Delayed-Action Preparations; D006885:Hydroxybutyrates; D007555:Isoxazoles; D009570:Nitriles; D011091:Polyesters; D011108:Polymers; D014052:Toluidines; C527525:teriflunomide; C033616:poly(lactide); C009204:butylene glycol adipic acid polyester; D000077339:Leflunomide
keywords: Aliphatic polyesters; Anti-rheumatoid; Controlled release; Electrospun nanofibers; Patches; Teriflunomide